A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) Formulations
Status:
Completed
Trial end date:
2016-06-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the multiple dose pharmacokinetics (PK) of three
gefapixant (AF-219) formulations; to assess the effect of Omeprazole on the multiple dose PK
of three gefapixant formulations; and, to assess the safety and tolerability of gefapixant.